Trials / Unknown
UnknownNCT03577574
Study of Two-step Anesthesia in Posterior Vitrectomy
A Prospective, Randomised, Single-masked Comparison of Retrobulbar Anesthesia, Peribulbar Anesthesia and Topical Combined Subconjunctival(Two-step) Anesthesia in Posterior Vitrectomy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Aier School of Ophthalmology, Central South University · Academic / Other
- Sex
- All
- Age
- 30 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, randomised, single-masked comparison of local anaesthetic approaches including topical anesthesia combined sub-conjunctival anesthesia(two-step anesthesia) for minimally invasive vitrectomy(TAMIV)vs peribulbar block vs retrobulbar block
Detailed description
Purpose: topical anesthesia combined sub-conjunctival anesthesia(two-step anesthesia) for minimally invasive vitrectomy Methods: This prospective, randomized, single-blinded clinical trail is conducted at Shanghai Aier Eye Hospital. Selected group of 60 patients with retinal-vitreous diseases will be randomized divided into 3 groups and underwent 25-gauge vitrectomy. Group1 uses two-step anesthesia , whereas Group 2 uses retrobulbar anesthesia, group 3 uses peribulbar anesthesia. A 5-point Visual Analogue Pain Scale is used to assess patients' pain score and surgeon's ease while operating. Any complications therefore will be made note of.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | retrobulbar anesthesia | 2% lidocaine 4ml injected into retrobulbar space |
| PROCEDURE | peribulbar anesthesia | 2% lidocaine 4 to 8ml injected into peribulbar space |
| PROCEDURE | two step anesthesia | conjunctival cul-de-sac anesthetized with 0.5% proparacaine hydrochloride drops three times + 2% lidocaine 0.6 to 0.8ml subconjunctival injection |
Timeline
- Start date
- 2018-08-02
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2018-07-05
- Last updated
- 2018-07-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03577574. Inclusion in this directory is not an endorsement.